Figure 3From: The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: An intravital microscopy study in mice A, B: A 549 lung carcinoma at day 28, hematoxylin-eosin stained cross section, scale bar 500 μm. Tumor borders marked by arrows. Control (A), Celecoxib (B). C, D: A 549 lung carcinoma at day 28, TUNEL reaction, scale bar 50 μm, apoptotic cells stained red. Control (C), Celecoxib (D).Back to article page